Kawasaki disease in an infant after administration of hexavalent vaccine

References

1. 1.↵
   1. Burns JC,
   2. Glodé MP.

   Kawasaki syndrome. Lancet 2004; 364: 533–544.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Principi N,
   2. Rigante D,
   3. Esposito S.

   The role of infection in Kawasaki syndrome. J Infect 2013; 67: 1–10.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Matsubara K,
   2. Fukaya T.

   The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease. Curr Opin Infect Dis 2007; 20: 298–303.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Hara T,
   2. Nakashima Y,
   3. Sakai Y,
   4. Nishio H,
   5. Motomura Y,
   6. Yamasaki S.

   Kawasaki disease: a matter of innate immunity. Clin Exp Immunol 2016; 186: 134–143.

   OpenUrlPubMed
5. 5.↵
   1. Phuong LK,
   2. Bonetto C,
   3. Buttery J,
   4. Pernus YB,
   5. Chandler R,
   6. Felicetti P, et al.

   Kawasaki disease and immunisation: a systematic review. Vaccine 2017; 35: 1770–1779.

   OpenUrl
6. 6.↵
   1. Treadwell TA,
   2. Maddox RA,
   3. Holman RC,
   4. Belay ED,
   5. Shahriari A,
   6. Anderson MS, et al.

   Investigation of Kawasaki syndrome risk factors in Colorado. Pediatr Infect Dis J 2002; 21: 976–978.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Abrams JY,
   2. Weintraub ES,
   3. Baggs JM,
   4. McCarthy NL,
   5. Schonberger LB,
   6. Lee GM, et al.

   Childhood vaccines and kawasaki disease, vaccine safety datalink, 1996-2006. Vaccine 2015; 33: 382–387.

   OpenUrl
8. 8.↵
   1. Hua W,
   2. Izurieta HS,
   3. Slade B,
   4. Penina Haber,
   5. Rosemary Tiernan, et al.

   Table, supplemental digital content 1- vaccine adverse event reporting system (Vaers) case definitions of Kawasaki disease (Kd). Pediatr Infect Dis J 2009; 28: 943–947.

   OpenUrlPubMed
9. 9.↵
   1. Halperin SA,
   2. Tapiero B,
   3. Law B,
   4. Diaz-Mitoma F,
   5. Duval B,
   6. Langley JM, et al.

   Interchangeability of two diphtheria and tetanus toxoids, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate vaccines as a fourth dose in 15-20-month-old toddlers. Vaccine 2006; 24: 4017–4023.

   OpenUrlPubMed
10. 10.↵
    1. Bulik NB.

    Hexavalent vaccine in Europe: safety data from the randomized clinical trials. Farmacia 2018; 66: 747–757.

    OpenUrl